In Friday’s Wall Street session, DocGo Inc (NASDAQ:DCGO) shares traded at $1.40, down -39.91% from the previous session.
DCGO stock price is now -45.14% away from the 50-day moving average and -61.12% away from the 200-day moving average. The market capitalization of the company currently stands at $139.92M.
On February 28, 2025, Deutsche Bank Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $5 to quote $2.85, while ‘BTIG Research’ rates the stock as ‘Buy’
In other news, Etalvina Leite, Officer bought 16,500 shares of the company’s stock on Dec 17 ’24. The stock was bought for $71,528 at an average price of $4.33. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 17 ’24, Director Leite Etalvina sold 16,500 shares of the business’s stock. A total of $71,610 was realized by selling the stock at an average price of $4.34. This leaves the insider owning 51,411 shares of the company worth $71975.4. A total of 13.28% of the company’s stock is owned by insiders.
During the past 12 months, DocGo Inc has had a low of $2.02 and a high of $5.68. As of last week, the company has a debt-to-equity ratio of 0.20, a current ratio of 2.44, and a quick ratio of 2.44.
The net profit margin was -0.12% and return on equity was -0.21% for DCGO. The company reported revenue of $96.03 million for the quarter, compared to $192.09 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -50.01 percent.
